One stem cell generates 14 million tumor-killing NK cells in major cancer breakthrough
Chinese Academy of Sciences researchers developed a method that generates up to 14 million NK cells from a single CD34+ cord blood stem cell, including CAR-equipped NK variants. Published in Nature Biomedical Engineering, the approach promises streamlined, large-scale manufacture for adoptive immunotherapy.
Why it mattersCD34-derived CAR-iNK production enables developers to prioritize allogeneic CAR-NK manufacturing capacity investments.